Why Cheap, Older Drugs That Might Treat COVID Never Get Out of the Lab

medscape.com
April 19, 2022

Lack of profit delays the approval process of older, cheaper, and possibly safer and more effective drugs for COVID-19 and Long-COVID.

Be the First to Know

Sign up to get updates when we add new off-label treatments, articles, videos, and clinical trials!